Ionis Pharmaceuticals's total assets for Q3 2024 were $3.08B, an increase of 14.49% from the previous quarter. IONS total liabilities were $2.42B for the fiscal quarter, a 95.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.